请输入您要查询的百科知识：

　

词条 (+)-Naloxone
释义

  1. Relation of TLR4 to opioid drugs

  2. Applications of (+)-naloxone and related drugs

  3. See also

  4. References

{{Drugbox
| verifiedrevid = 477200552
| IUPAC_name = (1R,5S,13S,17R)- 10,17-dihydroxy- 4-(prop-2-en-1-yl)- 12-oxa- 4-azapentacyclo [9.6.1.0{{sup|1,13}}.0{{sup|5,17}}.0{{sup|7,18}}] octadeca- 7(18),8,10-trien- 14-one
| image = plusnaloxone_structure.png
| tradename =
| MedlinePlus = a601092
| pregnancy_category =
| legal_status = Investigational
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 65700-73-4
| ATC_prefix =
| ATC_suffix =
| PubChem = 5491858
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4590735
| C=19 | H=21 | N=1 | O=4
| molecular_weight = 327.374 g/mol
| smiles = C=CCN1CC[C@@]23[C@H]4C(=O)CC[C@@]2([C@@H]1CC5=C3C(=C(C=C5)O)O4)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UZHSEJADLWPNLE-PIKADFDJSA-N
}}(+)-Naloxone (dextro-naloxone) is a drug which is the "unnatural" enantiomer of the opioid antagonist drug (−)-naloxone. Unlike "normal" naloxone, (+)-naloxone has no significant affinity for opioid receptors,[1] but instead has been discovered to act as a selective antagonist of Toll-like receptor 4. This receptor is involved in immune system responses, and activation of TLR4 induces glial activation and release of inflammatory mediators such as TNF-α and Interleukin-1.[2][3]

Relation of TLR4 to opioid drugs

Both "normal" and "unnatural" enantiomers of various opioid analgesic drugs including morphine, meperidine, fentanyl, methadone and buprenorphine, as well as some otherwise inactive metabolites like morphine-3-glucuronide, have been found to act as agonists of TLR4, and chronic use of these drugs consequently causes constant low-level release of TNF-α and IL-1β as well as other downstream effects. This is thought to be involved in various adverse properties of opioid analgesic drugs, such as loss of efficacy with extended use and the associated development of tolerance and dependence, as well as the development of side effects such as hyperalgesia and allodynia, which can cause long-term use of opioid analgesics to not only fail to treat neuropathic pain, but ultimately exacerbate it.[4][5]

Applications of (+)-naloxone and related drugs

Several opioid antagonist drugs were found to act as antagonists for TLR4, including naloxone and naltrexone. However it was found that not only the "normal" (-) enantiomers, but also the "unnatural" (+) enantiomers of these drugs acted as TLR4 antagonists (though (+)-nalmefene was inactive). Since (+)-naloxone and (+)-naltrexone lack affinity for opioid receptors, they do not block the effects of opioid analgesic drugs, and so can be used to counteract the TLR4-mediated side effects of opioid agonists without affecting analgesia,[6] though (+)-naloxone does reduce the reinforcing effects of opioid drugs.[7] (+)-Naloxone was also found to be neuroprotective,[8][9] and both (+)-naloxone and (+)-naltrexone are effective in their own right at treating symptoms of neuropathic pain in animal models.[10][11] However (+)-naloxone was also found to reduce the effects of stimulant drugs,[12][13] suggesting additional actions beyond TLR4 antagonism (possibly as a sigma receptor antagonist),[14] that might potentially result in unwanted side effects or drug interactions.

See also

  • Dextromethorphan
  • Eritoran
  • Methylnaltrexone

References

1. ^{{Cite journal | doi = 10.1021/jm00202a018 | last1 = Iijima | first1 = I. | last2 = Minamikawa | first2 = J. | last3 = Jacobson | first3 = A. E. | last4 = Brossi | first4 = A. | last5 = Rice | first5 = K. C. | last6 = Klee | first6 = W. A. | title = Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone | journal = Journal of Medicinal Chemistry | volume = 21 | issue = 4 | pages = 398–400 | year = 1978 | pmid = 206698}}
2. ^{{cite journal | last1 = Wu | first1 = Hsiang-En | last2 = Thompson | first2 = Jonathan | last3 = Sun | first3 = Han-Sen | last4 = Terashvili | first4 = Maia | last5 = Tseng | first5 = Leon F. | title = Antianalgesia: stereoselective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord |journal=The Journal of Pharmacology and Experimental Therapeutics |volume=314 |issue=3 |pages=1101–8 |date=September 2005|pmid=15901793 |doi=10.1124/jpet.105.087130 |url=}}
3. ^{{Cite journal | last1 = Watkins | first1 = Linda R.| last2 = Hutchinson | first2 = Mark R.| last3 = Rice | first3 = Kenner C.| last4 = Maier | first4 = Steven F.| title = The "Toll" of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia | doi = 10.1016/j.tips.2009.08.002 | journal = Trends in Pharmacological Sciences| volume = 30 | issue = 11 | pages = 581–591 | year = 2009 | pmid = 19762094| pmc = 2783351}}
4. ^{{Cite journal | last1 = Hutchinson | first1 = Mark R.| last2 = Zhang | first2 = Yingning| last3 = Shridhar | first3 = Mitesh| last4 = Evans | first4 = John H.| last5 = Buchanan | first5 = Madison M.| last6 = Zhao | first6 = Tina X.| last7 = Slivka | first7 = Peter F.| last8 = Coats | first8 = Benjamen D.| last9 = Rezvani | first9 = Niloofar| last10 = Wieseler | first10 = Julie| last11 = Hughes | first11 = Travis S.| last12 = Landgraf | first12 = Kyle E.| last13 = Chan | first13 = Stefanie| last14 = Fong | first14 = Stephanie| last15 = Phipps | first15 = Simon| last16 = Falke | first16 = Joseph J.| last17 = Leinwand | first17 = Leslie A.| last18 = Maier | first18 = Steven F.| last19 = Yin | first19 = Hang| last20 = Rice | first20 = Kenner C.| last21 = Watkins | first21 = Linda R.| doi = 10.1016/j.bbi.2009.08.004 | title = Evidence that opioids may have toll-like receptor 4 and MD-2 effects | journal = Brain, Behavior, and Immunity| volume = 24 | issue = 1| pages = 83–95| year = 2010 | pmid = 19679181| pmc = 2788078}}
5. ^{{Cite journal | last1 = Hutchinson | first1 = Mark R.| last2 = Lewis | first2 = S. S. | last3 = Coats | first3 = Benjamen D.| last4 = Rezvani | first4 = Niloofar| last5 = Zhang | first5 = Y. | last6 = Wieseler | first6 = Julie L.| last7 = Somogyi | first7 = A. A. | last8 = Yin | first8 = Hang| last9 = Maier | first9 = Steven F.| last10 = Rice | first10 = Kenner C.| last11 = Watkins | first11 = Linda R.| doi = 10.1016/j.neuroscience.2010.02.011 | title = Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences | journal = Neuroscience| volume = 167 | issue = 3 | pages = 880–893 | date = 19 May 2010 | pmid = 20178837| pmc = 2854318 }}
6. ^{{cite journal | last1 = Wu | first1 = Hsiang-En | last2 = Sun | first2 = Han-Sen | last3 = Cheng | first3 = Caleb W. | last4 = Terashvili | first4 = Maia | last5 = Tseng | first5 = Leon F. | title = dextro-Naloxone or levo-naloxone reverses the attenuation of morphine antinociception induced by lipopolysaccharide in the mouse spinal cord via a non-opioid mechanism | journal = The European Journal of Neuroscience | volume=24 | issue=9 | pages=2575–2580 | date=November 2006 | pmid=17100845 | doi=10.1111/j.1460-9568.2006.05144.x |url=}}
7. ^{{Cite journal | display-authors = | last1 = Hutchinson | first1 = M. R. | last2 = Northcutt | first2 = A. L. | last3 = Hiranita | first3 = T. | last4 = Wang | first4 = X. | last5 = Lewis | first5 = S. S. | last6 = Thomas | first6 = J. | last7 = Van Steeg | first7 = K. | last8 = Kopajtic | first8 = T. A. | last9 = Loram | first9 = L. C.| first10 = C. | last10 = Sfregola| first11 = E. | last11 = Galer| first12 = N. E. | last12 = Miles| first13 = S. T. | last13 = Bland| first14 = J. | last14 = Amat| first15 = R. R. | last15 = Rozeske| first16 = T. | last16 = Maslanik| first17 = T. R. | last17 = Chapman| first18 = K. A. | last18 = Strand| first19 = M. | last19 = Fleshner| first20 = R. K. | last20 = Bachtell| first21 = A. A. | last21 = Somogyi| first22 = H. | last22 = Yin| first23 = J. L. | last23 = Katz| first24 = K. C. | last24 = Rice| first25 = S. F. | last25 = Maier| first26 = L. R. | last26 = Watkins| doi = 10.1523/JNEUROSCI.0684-12.2012 | title = Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement | journal = Journal of Neuroscience | volume = 32 | issue = 33 | pages = 11187–11200| date = 15 August 2012 | pmid = 22895704| pmc = 3454463}}
8. ^{{cite journal | last1 = Liu | first1 = Bin | last2 = Du | first2 = Lina | last3 = Hong | first3 = Jau-Shyong | title = Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation | journal = The Journal of Pharmacology and Experimental Therapeutics | volume=293 | issue=2 | pages=607–617 | date=1 May 2000| pmid=10773035 | doi= | url = http://jpet.aspetjournals.org/content/293/2/607 }}
9. ^{{cite journal | last1 = Liu | first1 = Yuxin | last2 = Qin | first2 = Liya | last3 = Wilson | first3 = Belinda C. | last4 = An | first4 = Lijia | last5 = Hong | first5 = Jau-Shyong | last6 = Liu | first6 = Bin | title = Inhibition by naloxone stereoisomers of β-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons |journal=The Journal of Pharmacology and Experimental Therapeutics |volume=302 |issue=3 |pages=1212–1219 |date=1 September 2002|pmid=12183682 |doi=10.1124/jpet.102.035956 |url=}}
10. ^{{Cite journal | last1 = Hutchinson | first1 = Mark R.| last2 = Zhang | first2 = Yingning| last3 = Brown | first3 = Kimberley| last4 = Coats | first4 = Benjamen D.| last5 = Shridhar | first5 = Mitesh| last6 = Sholar | first6 = Paige W.| last7 = Patel | first7 = Sonica J.| last8 = Crysdale | first8 = Nicole Y.| last9 = Harrison | first9 = Jacqueline A.| last10 = Maier | first10 = Steven F.| last11 = Rice | first11 = Kenner C.| last12 = Watkins | first12 = Linda R.| doi = 10.1111/j.1460-9568.2008.06321.x | title = Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4) | journal = European Journal of Neuroscience| volume = 28 | issue = 1 | pages = 20–29 | date = July 2008 | pmid = 18662331| pmc = 2588470 }}
11. ^{{Cite journal | display-authors = | last1 = Lewis | first1 = Susannah S.| last2 = Loram | first2 = Lisa C.| last3 = Hutchinson | first3 = Mark R.| last4 = Li | first4 = Chien-Ming| last5 = Zhang | first5 = Yingning| last6 = Maier | first6 = Steven F.| last7 = Huang | first7 = Yong| last8 = Rice | first8 = Kenner C.| last9 = Watkins | first9 = Linda R.| doi = 10.1016/j.jpain.2012.02.005 | title = (+)-Naloxone, an Opioid-Inactive Toll-Like Receptor 4 Signaling Inhibitor, Reverses Multiple Models of Chronic Neuropathic Pain in Rats | journal = The Journal of Pain| volume = 13 | issue = 5 | pages = 498–506 | year = 2012 | pmid = 22520687 | pmc =3348259 }}
12. ^{{cite journal | pmid = 8829141 | volume = 21 | issue = 6 | title = Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity | date = June 1996 | journal = Neurochemical Research | pages=691–3 | last1 = Chatterjie | first1 = Nithiananda | last2 = Alexander | first2 = George J. | last3 = Sechzer | first3 = Jeri A. | last4 = Lieberman | first4 = Kenneth W. | doi = 10.1007/BF02527726 }}
13. ^{{cite journal | last1 = Chatterjie | first1 = Nithiananda | last2 = Sechzer | first2 = Jeri A. | last3 = Lieberman | first3 = Kenneth W. | last4 = Alexander | first4 = George J. | title = Dextro-naloxone counteracts amphetamine-induced hyperactivity |journal=Pharmacology Biochemistry and Behavior | volume = 59 | issue = 2 | pages = 271–274 | date = February 1998 | pmid = 9476969 | doi = 10.1016/S0091-3057(97)00528-5 | url = }}
14. ^{{Cite journal | last1 = Wu | first1 = Hsiang-en| last2 = Hong | first2 = Jau-Shyong| last3 = Tseng | first3 = Leon F.| doi = 10.1016/j.ejphar.2007.06.012 | title = Stereoselective action of (+)-morphine over (−)-morphine in attenuating the (−)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse | journal = European Journal of Pharmacology| volume = 571 | issue = 2–3 | pages = 145–151 | date = 1 October 2007 | pmid = 17617400| pmc = 2080825 }}
{{DEFAULTSORT:Naloxone, (+)-}}

2 : Experimental drugs|Allyl compounds
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/11/13 11:58:50